Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Cardiomyopathy | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Cardiomyopathy | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Stem Cell Injection in Cancer Survivors
Condition: Cardiomyopathy Due to Anthracyclines
Interventions: Biological: Allo-MSCs;   Biological: Placebo
2 Recruiting Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Conditions: Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-Cell Leukemia/Lymphoma;   Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Adult T-Cell Leukemia/Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Adult T-Cell Leukemia/Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult T-Cell Leukemia/Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult T-Cell Leukemia/Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Other: Assessment of Therapy Complications;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
3 Recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
4 Recruiting Exercise in Genetic Cardiovascular Conditions
Conditions: Hypertrophic Cardiomyopathy;   Long QT Syndrome
Intervention:
5 Recruiting Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Valsartan;   Drug: Placebo
6 Recruiting Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure
Condition: Ischemic Cardiomyopathy
Interventions: Biological: Mesenchymal Stem Cells (MSC);   Biological: Cardiac Stem Cells (CSC);   Biological: Placebo (Plasmalyte A)
7 Recruiting Hypertrophic Regression With N-Acetylcysteine in HCM
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
8 Recruiting Molecular Imaging of Primary Amyloid Cardiomyopathy
Conditions: Amyloidosis, Primary;   Cardiomyopathy
Interventions: Radiation: F-18 florbetapir/C-11 acetate PET;   Device: MRI
9 Recruiting Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
Conditions: Heart Failure;   Cardiomyopathy;   Ventricular Dysfunction
Interventions: Biological: MPC Intramyocardial Injection;   Drug: Control Solution
10 Recruiting Group Medical Visits in Heart Failure
Condition: Heart Failure
Intervention: Behavioral: Group medical visits
11 Recruiting A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
Condition: Heart Failure
Interventions: Other: Brain Imaging (Neuroimaging);   Other: Cognitive Function Assessment
12 Recruiting Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
Conditions: Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Optimal Medical Therapy
13 Recruiting Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Condition: BRAF V600E Mutation
Interventions: Drug: Dabrafenib Mesylate;   Drug: Trametinib Dimethyl Sulfoxide
14 Recruiting Rhode Island Diastolic Dysfunction - Heart Failure
Conditions: Heart Failure;   Cardiovascular Disease
Intervention: Drug: Kuvan
15 Recruiting Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
Conditions: Dilated Cardiomyopathy;   Hypertrophic Cardiomyopathy;   Restrictive Cardiomyopathy
Intervention:
16 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
17 Recruiting Lipid Biomarkers for Diabetic Heart Disease
Conditions: Type II Diabetes Mellitus;   Diabetes Complications
Interventions: Drug: Fenofibrate;   Drug: Placebo for fenofibrate
18 Recruiting Radiation-Free Heart Catheterization Using MRI
Conditions: Aortic Coarctation;   Cardiomyopathy;   Atrial Septal Defect;   Aortic Stenosis;   Post Heart Transplant Catheter Procedure;   Patent Ductus Arteriosus
Interventions: Procedure: MRI guided cardiac catheterization;   Device: Magnetic resonance imaging
19 Recruiting Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Conditions: Heart Failure, Congestive;   Death, Sudden, Cardiac;   Arrhythmia;   Cardiomyopathies
Intervention:
20 Not yet recruiting Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
Conditions: Sudden Cardiac Death;   Ventricular Tachycardia;   Ventricular Fibrillation;   Cardiomyopathy
Interventions: Procedure: Cardiac Sympathetic Denervation (CSD);   Drug: Routine Care

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.